Rare Cancer Drug Market Surges 7.3% Annually as Novel Therapies Transform PCPG Treatment
PCPG cancer market projects 7.3% annual growth through 2036, valued at USD 300M in 2025, driven by novel drug classes and Novartis WELIREG leadership.
MRKNVSBHCCATXJAZZmarket growthradioligand therapy